This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Nee, L. E. Articles by Lippa, C. F. Search for Related Content PubMed PubMed Citation Articles by Nee, L. E. Articles by Lippa, C. F. Social Bookmarking                         What's this?

Inherited Alzheimer's disease PS-1 olfactory function: A 10-year follow-up study

Family Studies Unit, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland

Carol F. Lippa, MD

Department of Neurology, Medical College of Pennsylvania, Hahnemann University, Philadelphia, Pennsylvania

This study was undertaken to evaluate smell tests as a clinical marker for identifying mutation carrier status and determining the clinical diagnosis of presenilin-1 Alzheimer's disease (AD) in family members of those afflicted with the disease. Ten years ago, we gave the self-administered, 40-question scratch and sniff University of Pennsylvania Smell Identification Test to 18 atrisk family members, individuals with dominantlyinherited Alzheimer's disease.

Testing results were normal 10 years ago except in the case of one individual who had smoked three packs of cigarettes a day for more than 23 years. Four subjects tested in 1990 are now afflicted with Alzheimer's disease, including the smoker. The smell test in 1990 did not demonstrate predictive capabilities before clinical conversion to dementia. At follow-up, two subjects were too impaired to take the test. Two "converted" from normal smell function toabnormal function with a wide range in score. Study findings indicate that the smell test is too variable a measure to be used as a reliable test for predicting or verifying a diagnosis of presenilin-1 Alzheimer's disease.

American Journal of Alzheimer's Disease and Other Dementias®, Vol. 16, No. 2, 83-84 (2001)
DOI: 10.1177/153331750101600210


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?